Articles with "h3r" as a keyword



Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson's Disease.

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.0c00914

Abstract: Adenosine A1/A2A receptors (A1R/A2AR) represent targets in nondopaminergic treatment of motor disorders such as Parkinson's disease (PD). As an innovative strategy, multitargeting ligands (MTLs) were developed to achieve comprehensive PD therapies simultaneously addressing comorbid symptoms… read more here.

Keywords: treatment; a1r a2ar; parkinson disease; h3r ... See more keywords

In-silico discovery of dual active molecule to restore synaptic wiring against autism spectrum disorder via HDAC2 and H3R inhibition

Sign Up to like & get
recommendations!
Published in 2022 at "PLoS ONE"

DOI: 10.1371/journal.pone.0268139

Abstract: Metal-dependent histone deacetylases (HDACs) are essential epigenetic regulators; their molecular and pharmacological roles in medically critical diseases such as neuropsychiatric disorders, neurodegeneration, and cancer are being studied globally. HDAC2’s differential expression in the central nervous… read more here.

Keywords: dual active; autism spectrum; spectrum disorder; h3r ... See more keywords

First Report on Cationic Triphenylphosphonium Compounds as Mitochondriotropic H3R Ligands with Antioxidant Properties

Sign Up to like & get
recommendations!
Published in 2024 at "Antioxidants"

DOI: 10.3390/antiox13111345

Abstract: Neurodegenerative diseases are a major public health problem due to the aging population and multifaceted pathology; therefore, the search for new therapeutic alternatives is of the utmost importance. In this sense, a series of six… read more here.

Keywords: ligands antioxidant; antioxidant properties; first report; neurodegenerative diseases ... See more keywords

Simultaneous Antagonism at H3R/D2R/D3R Reduces Autism-like Self-Grooming and Aggressive Behaviors by Mitigating MAPK Activation in Mice

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Molecular Sciences"

DOI: 10.3390/ijms24010526

Abstract: Dysregulation in brain neurotransmitters underlies several neuropsychiatric disorders, e.g., autism spectrum disorder (ASD). Also, abnormalities in the extracellular-signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway pave the way for neuroinflammation, neurodegeneration, and altered learning phenotype in… read more here.

Keywords: aggressive behaviors; grooming aggressive; h3r; mapk pathway ... See more keywords